Clinical Trial Update: Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

A Phase 1 trial examining the effect of tranilast on the pharmacokinetics of methotrexate in rheumatoid arthritis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tranilast (tranilast)

Snippet

Sponsor: Imperial College London | Conditions: Rheumatoid Arthritis | Phase 1 | Status: WITHDRAWN